Skip to main content

Table 4 Multivariate analysis for distant metastases-free survival (DMFS) and overall survival (OS)

From: High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy

 

RR

DMFS

 

RR

OS

 

95% CI

p-value

95% CI

p-value

Sex

      

Male/female

1.33

0.14–12.94

0.81

1.07

0.27–4.21

0.92

HIV-status

      

Positive/negative

0.24

0.03–2.08

0.20

0.43

0.09–2.00

0.28

T-stage

      

T1–2/T3–4

1.88

1.10–3.21

0.02

1.31

0.96–1.80

0.08

N-stage

      

N0/N+

1.35

0.89–2.03

0.15

1.18

0.95–1.48

0.14

Grading

      

G1-2/G3

1.62

0.91–2.89

0.10

1.15

0.79–1.67

0.47

Survivin

      

Low*/high**

0.04

0.003–0.59

0.02

0.27

0.08–0.92

0.04

  1. Abbreviations: DMFS = distant metastases-free survival; OS = overall survival; RR = relative risk; CI = confidence interval; HIV = human immunodeficiency virus. *Survivin - weighted score ≤ 8; **survivin - weighted score > 8.